{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:58:57Z","timestamp":1791212337345,"version":"4.1.0"},"reference-count":38,"publisher":"The Journal of Rheumatology","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2016,11]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>Cardiovascular disease (CVD) is a major comorbidity for patients with rheumatoid arthritis (RA). This study sought to determine the performance of 11 recently developed CVD quality indicators (QI) for RA in clinical practice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>Medical charts for patients with RA (early disease or biologic-treated) followed at 1 center were retrospectively reviewed. A systematic assessment of adherence to 11 QI over a 2-year period was completed. Performance on the QI was reported as a percentage pass rate.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>There were 170 charts reviewed (107 early disease and 63 biologic-treated). The most frequent CVD risk factors present at diagnosis (early disease) and biologic start (biologic-treated) included hypertension (26%), obesity (25%), smoking (21%), and dyslipidemia (15%). Performance on the CVD QI was highly variable. Areas of low performance (&lt; 10% pass rates) included documentation of a formal CVD risk assessment, communication to the primary care physician (PCP) that patients with RA were at increased risk of CVD, body mass index documentation and counseling if overweight, communication to a PCP about an elevated blood pressure, and discussion of risks and benefits of antiinflammatories in patients at CVD risk. Rates of diabetes screening and lipid screening were 67% and 69%, respectively. The area of highest performance was observed for documentation of intent to taper corticosteroids (98%\u2013100% for yrs 1 and 2, respectively).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>Gaps in CVD risk management were found and highlight the need for quality improvements. Key targets for improvement include coordination of CVD care between rheumatology and primary care, and communication of increased CVD risk in RA.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.160241","type":"journal-article","created":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T01:58:20Z","timestamp":1470103100000},"page":"1965-1973","source":"Crossref","is-referenced-by-count":26,"title":["Gaps in Addressing Cardiovascular Risk in Rheumatoid Arthritis: Assessing Performance Using Cardiovascular Quality Indicators"],"prefix":"10.3899","volume":"43","author":[{"given":"Claire E.H.","family":"Barber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Esdaile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam O.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Faris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Barnabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selynne","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Lopatina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2016,8,1]]},"reference":[{"key":"2018112909362412000_43.11.1965.1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200726"},{"key":"2018112909362412000_43.11.1965.2","doi-asserted-by":"publisher","DOI":"10.1186\/ar3538"},{"key":"2018112909362412000_43.11.1965.3","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu459"},{"key":"2018112909362412000_43.11.1965.4","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq378"},{"key":"2018112909362412000_43.11.1965.5","doi-asserted-by":"publisher","DOI":"10.1186\/ar1717"},{"key":"2018112909362412000_43.11.1965.6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044668"},{"key":"2018112909362412000_43.11.1965.7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu403"},{"key":"2018112909362412000_43.11.1965.8","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-015-0576-7"},{"key":"2018112909362412000_43.11.1965.9","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e32834ff2fd"},{"key":"2018112909362412000_43.11.1965.10","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22553"},{"key":"2018112909362412000_43.11.1965.11","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-011-1747-9"},{"key":"2018112909362412000_43.11.1965.12","doi-asserted-by":"publisher","DOI":"10.1186\/ar4118"},{"key":"2018112909362412000_43.11.1965.13","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204223"},{"key":"2018112909362412000_43.11.1965.14","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21935"},{"key":"2018112909362412000_43.11.1965.15","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.141603"},{"key":"2018112909362412000_43.11.1965.16","first-page":"1493","article-title":"Efficacy of methotrexate monotherapy compared to combination therapy with methotrexate and hydroxychloroquine in the treatment of early rheumatoid arthritis after 12 months of treatment","volume":"41","author":"Dissanayake","year":"2014","journal-title":"J Rheumatol"},{"key":"2018112909362412000_43.11.1965.17","first-page":"607","article-title":"Efficacy of methotrexate monotherapy compared to methotrexate and hydroxychloroquine in the treatment of early rheumatoid arthritis","volume":"70","author":"Dissanayake","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2018112909362412000_43.11.1965.18","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.131451"},{"issue":"Suppl 35","key":"2018112909362412000_43.11.1965.19","first-page":"S39","article-title":"Mandatory pharmacosurveillance\u2014a Canadian model for access to therapy and research","volume":"22","author":"Barr","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"2018112909362412000_43.11.1965.20","doi-asserted-by":"publisher","DOI":"10.1002\/art.27584"},{"key":"2018112909362412000_43.11.1965.21","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.113696"},{"key":"2018112909362412000_43.11.1965.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2005.01.002"},{"key":"2018112909362412000_43.11.1965.23","unstructured":"Linden A . Framingham: Stata module for calculating the Framingham 10-year coronary vascular disease risk prediction. [Internet. Accessed June 22, 2016.] Available from: ideas.repec.org\/c\/boc\/bocode\/s457997.html#author"},{"key":"2018112909362412000_43.11.1965.24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.699579"},{"key":"2018112909362412000_43.11.1965.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2012.11.032"},{"key":"2018112909362412000_43.11.1965.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2012.03.044"},{"key":"2018112909362412000_43.11.1965.27","unstructured":"DAS 28-score Website . [Internet. Accessed June 22, 2016.] Available from: www.das-score.nl\/das28\/en"},{"key":"2018112909362412000_43.11.1965.28","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380107"},{"issue":"Suppl 39","key":"2018112909362412000_43.11.1965.29","first-page":"S14","article-title":"The Health Assessment Questionnaire (HAQ)","volume":"23","author":"Bruce","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"2018112909362412000_43.11.1965.30","doi-asserted-by":"publisher","DOI":"10.1177\/001316446002000104"},{"key":"2018112909362412000_43.11.1965.31","unstructured":"Oleckno WA . Epidemiology: concepts and methods. Long Grove: Waveland Press Inc.; 2008."},{"key":"2018112909362412000_43.11.1965.32","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(90)90159-M"},{"key":"2018112909362412000_43.11.1965.33","doi-asserted-by":"publisher","DOI":"10.1002\/art.37975"},{"key":"2018112909362412000_43.11.1965.34","doi-asserted-by":"publisher","DOI":"10.1002\/art.30239"},{"key":"2018112909362412000_43.11.1965.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2012.01.005"},{"key":"2018112909362412000_43.11.1965.36","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22302"},{"key":"2018112909362412000_43.11.1965.37","unstructured":"The Royal Australian College of General Practitioners . Clinical guideline for the diagnosis and management of early rheumatoid arthritis: August 2009. [Internet. Accessed June 22, 2016.] Available from: www.racgp.org.au\/download\/documents\/Guidelines\/Musculoskeletal\/racgp_ra_guideline.pdf"},{"key":"2018112909362412000_43.11.1965.38","unstructured":"Canadian Society for Exercise Physiology . 24-hour movement guidelines for children and youth. [Internet. Accessed June 22, 2016.] Available from: www.csep.ca\/en\/guidelines\/get-the-guidelines"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.160241","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T19:12:37Z","timestamp":1543518757000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.160241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,1]]},"references-count":38,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,11,1]]},"published-print":{"date-parts":[[2016,11]]}},"alternative-id":["10.3899\/jrheum.160241"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.160241","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,1]]}}}